Clinical Trial Update: Safety and Acceptability of Deferiprone Delayed Release Tablets in Patients With Systemic Iron Overload [Phase 2]

View source ↗

Summary

Phase 2 trial updating safety and acceptability of deferiprone delayed release tablets in patients with iron overload due to repeated red blood cell transfusion…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload Due to Repeated Red Blood Cell Transfusions

Drugs mentioned

• Deferiprone delayed release tablets (deferiprone)

Snippet

Sponsor: ApoPharma | Conditions: Iron Overload Due to Repeated Red Blood Cell Transfusions | Phase 2 | Status: COMPLETED | Results posted: 2021-06-18